PhotoZyne will seek expanded laboratory space in Buffalo – possibly at one of the facilities on the Buffalo Niagara Medical Campus – as it continues research and development into technology that aims to deliver cancer therapies without the severe effects of chemotherapy. The company will simultaneously pursue federal grants in the Small Tech Transfer Research program, which includes a phase one award of $225,000 and a phase two award of $1.5 million. “It’s a platform technology, so it has…